Enzon Pharmaceuticals, Inc. (BST:EZ1)
0.0555
0.00 (0.00%)
At close: Oct 16, 2025
Enzon Pharmaceuticals Market Cap
Enzon Pharmaceuticals has a market cap or net worth of €4.71 million as of October 17, 2025. Its market cap has decreased by -53.03% in one year.
Market Cap
4.71M
Enterprise Value
4.07M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.06
Market Cap Chart
Since January 16, 1990, Enzon Pharmaceuticals's market cap has decreased from 90.54M to 4.71M, a decrease of -94.80%. That is a compound annual growth rate of -7.93%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 17, 2025 | 4.71M | -57.92% |
Dec 31, 2024 | 11.19M | 78.15% |
Dec 29, 2023 | 6.28M | -63.33% |
Dec 30, 2022 | 17.13M | -23.37% |
Dec 31, 2021 | 22.35M | 48.31% |
Dec 31, 2020 | 15.07M | 85.68% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 268.96B |
Siemens Aktiengesellschaft | 184.37B |
Deutsche Telekom AG | 142.21B |
Allianz SE | 132.28B |
Siemens Energy AG | 85.97B |
Rheinmetall AG | 76.23B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.84B |
Deutsche Bank Aktiengesellschaft | 54.72B |